Venus Medtech appoints Peter Ma as R&D VP

On September 27, 2021, Venus Medtech (Hangzhou) Inc. ("Venus Medtech", 2500.HK), a leading comprehensive platform company for innovative structural heart disease devices in China, announced the appointment of Peter Ma as Vice President of R&D Department.

Before joining Venus Medtech, Peter Ma worked as Director of Innovation and Strategic Marketing in Greater China, and Director of R&D in Greater China and Asia Pacific at Becton, Dickinson and Company. Early on, he served as Senior Project Manager and Senior R&D Engineer at Medtronic, and Senior Hardware Engineer at Philips Healthcare. Peter Ma has many years of experience in the R&D of medical devices and is well-versed in the development of Class III medical devices, including Class III interventional devices and surgical consumables.

Peter Ma said, "It is a great honor to join Venus Medtech! As a leading company in structural heart disease, Venus Medtech boasts internationally competitive innovative pipelines. I will make full use of my rich R&D experience and work closely with the team to help deliver the company’s international strategy."

Eric Zi, Founder, Chief Executive Officer and General Manager of Venus Medtech, said, "It’s an absolute delight to have another professional medical device veteran joining Venus Medtech. I believe Peter will guide and reshape our R&D force with his expertise, dedication, and leadership. And I’m sure he’ll soon fit in the role with his excellent learning ability. I look forward to his contribution to our next stage."

Prev:Created-in-China VenusP-Valve outperforms international counterpart, say two long-term cli···

Next:Venus Medtech appoints Shakeel Osman as Senior VP of Sales Europe to drive commercializati···